Examkin

Soru

Zorluk: ZorPreventive Care and Immunizations

A pediatric clinic is auditing patient records to ensure adherence to specialized immunization guidelines for high-risk patients. Match each pediatric patient scenario with the most appropriate vaccine indication, absolute contraindication, or management step.

  • A 4-year-old child with a newly placed cochlear implant who has received all routine childhood vaccinationsIndicated to receive the 23-valent pneumococcal polysaccharide vaccine (PPSV23)
  • A 10-year-old child with sickle cell anemia presenting for a well-child visit, previously up-to-date on all condition-specific vaccinationsIndicated to initiate the meningococcal serogroup B (MenB) vaccine series
  • A 12-month-old infant with DiGeorge syndrome and a documented severe T-lymphocyte deficiencyAbsolutely contraindicated to receive the live-attenuated measles, mumps, and rubella (MMR) vaccine
  • A 7-year-old child who received high-dose intravenous immunoglobulin (IVIG) for Kawasaki disease exactly 3 months agoRequires temporary deferral of live-attenuated vaccines (e.g., MMR, varicella) for an additional 8 months
  • A 15-year-old adolescent presenting for catch-up immunizations with a documented history of anaphylaxis to baker's yeastAbsolutely contraindicated to receive both the recombinant hepatitis B and human papillomavirus (HPV) vaccines

Cevap

The correct pairings match each specialized clinical scenario to its corresponding vaccine management guideline based on structural defects (PPSV23 for cochlear implants), functional asplenia (MenB starting at age 10), severe cellular immunodeficiency (absolute MMR contraindication), passive immunity interference (11-month live vaccine deferral post-IVIG), and specific allergies (HepB/HPV contraindication for yeast allergy).
Each patient requires a specialized modification to the routine immunization schedule. Cochlear implants necessitate PPSV23 due to an increased risk of pneumococcal meningitis from potential CSF leaks. Functional asplenia requires MenB starting at age 10. Severe T-cell defects are absolute contraindications to live vaccines (MMR). High-dose IVIG for Kawasaki disease requires an 11-month temporary deferral of live vaccines (yielding 8 months remaining if 3 months have passed). Yeast anaphylaxis strictly contraindicates the HepB and HPV vaccines.

Adım Adım Çözüm

1
Identify the underlying high-risk condition or status in each pediatric patient.
Recognize the presence of a cochlear implant, functional asplenia (sickle cell), severe T-cell deficiency, recent high-dose IVIG, and baker's yeast anaphylaxis.
Vaccine indications and contraindications depend heavily on these specific historical and clinical details rather than chronological age alone.
2
Determine appropriate pneumococcal and meningococcal vaccine indications for structural and functional defects.
The 4-year-old with a cochlear implant needs PPSV23. The 10-year-old with sickle cell anemia is newly eligible to start the MenB series.
Cochlear implants selectively increase pneumococcal meningitis risk (PPSV23 indicated >2 yrs). Asplenia increases broad encapsulated risk, and MenB is specifically approved and initiated at age 10.
3
Differentiate between temporary deferrals and absolute contraindications for live-attenuated vaccines.
The infant with severe T-cell deficiency has an absolute contraindication to MMR. The child who received IVIG 3 months ago requires an 11-month total deferral (8 additional months remaining).
Cellular immunodeficiency carries a fatal risk of vaccine-strain infection (absolute). Passive antibodies from IVIG merely blunt the immune response without causing harm (temporary).
4
Identify vaccine components related to specific severe allergies.
The adolescent with baker's yeast anaphylaxis cannot receive Hepatitis B or HPV vaccines.
Both of these vaccines are propagated in Saccharomyces cerevisiae and contain residual yeast proteins.

Anahtar Kavram

Vaccine modifications in special pediatric populations (immunocompromised, anatomic/functional defects, and specific allergies)
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Preventive Care and Immunizations

Bu konudan daha fazla soru